# Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)

> **NCT00652431** · PHASE1 · COMPLETED · sponsor: **Organon and Co** · enrollment: 18 (actual)

## Conditions studied

- Hypercholesterolemia
- Hyperlipidemia

## Interventions

- **DRUG:** Vytorin + Niaspan
- **DRUG:** Vytorin
- **DRUG:** Niaspan

## Key facts

- **NCT ID:** NCT00652431
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00652431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00652431, "Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00652431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*